SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, inclusive (the “Class Period”), have until November 7, 2023 to seek…Read More
INVESTOR DEADLINE NEXT WEEK Robbins Geller Rudman Dowd LLP Announces that Tandem Diabetes Care Inc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit TNDM
